drugset / Trial / NCT06900764

A Study of CAR-T Cells in Subjects With Systemic Lupus Erythematosus

NCT06900764

NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety and efficacy of CAR-T cell therapy in Subjects with SLE.

Timeline

Start
2025-10-10
Primary completion
2027-11-15
Completion
2027-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject CAR-T cell Cell therapy